Regenerative Biologics Supplier for Orthopedic Practices in Peoria, IL

Vendor qualification before an order is placed

Orthopedic practices and surgery centers typically assign vendor qualification to a practice administrator, compliance officer, or the ordering physician directly. Before any product moves, most groups request the certificate of analysis for the specific lot, a donor eligibility summary, and the lot release record showing that sterility testing and internal release criteria were satisfied.

Because tissue products carry a unique lot identifier, practices can request this documentation lot by lot rather than relying on a single blanket assurance for an entire product line.

Opening an NPI-verified account

Precision Biologics opens accounts for licensed professionals only. Account setup requires an NPI number, which Precision Biologics checks against the federal NPI registry, along with basic practice information.

This verification step exists because orders are restricted to licensed clinics, physician-supervised medspas, and physicians, and it is separate from and does not substitute for a practice's own credentialing or medical-director review.

Cold-chain receiving for Midwest shipments

Cryopreserved Wharton's jelly and exosome products ship overnight on dry ice in validated containers after slow-rate freezing and storage at -80 degrees Celsius. A practice in Peoria receiving a shipment should have a staff member available to move the container directly into appropriate storage rather than leaving it at a front desk or loading dock.

Each lot is tracked at the patient record level once it reaches the clinic, so practices should have a process for logging the lot identifier against the record it is used with before the product is ever opened.

Regulatory verification and ongoing support

Whether a given product and intended use fits within a practice's own regulatory posture is a determination for the practice and its counsel, not for Precision Biologics. Orthopedic groups in Illinois should verify their own standing with the Illinois medical board and with legal counsel before incorporating any product into a procedure.

Precision Biologics supports the administrative side of account setup: NPI verification, documentation requests, and access to physician-level calls about product specifications. These calls address documentation and sourcing questions, not clinical decision-making.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.